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Summary
Multiple synostoses syndrome is an autosomal dominant
disorder characterized by premature onset of joint fu-
sions, which initially affect the interphalangeal joints, by
characteristic facies, and by deafness. We performed
linkage analysis on a large Hawaiian family with mul-
tiple synostoses syndrome. Because another autosomal
dominant disorder, proximal symphalangism, shares
some clinical symptoms with multiple synostoses syn-
drome and has been linked to markers at loci at chro-
mosome 17q21-22, we tested the hypothesis that mul-
tiple synostoses syndrome is linked to the same
chromosomal region. Using polymorphic markers from
the proximal symphalangism interval, we conducted
linkage analysis and showed that the multiple synosto-
ses–syndrome phenotype is linked to the same chro-
mosomal region. A maximum LOD score of 3.98 at
recombination fraction of .00 was achieved for the
marker at locus D17S787. Further genetic analysis iden-
tified individuals with recombinant genotypes, allowing
localization of the disease gene within the interval
D17S931–D17S792, a 16-cM region. These data pro-
vide evidence that multiple synostoses syndrome and
proximal symphalangism may be allelic disorders.
Introduction
Multiple synostoses syndrome (OMIM 186400 and
186500) is a rare autosomal dominant dysostosis pri-
marily characterized by premature joint ankylosis, or
Received January 21, 1998; accepted for publication April 21, 1998;
electronically published May 29, 1998.
Address for correspondence and reprints: Dr. Daniel H. Cohn,
Medical Genetics SSB-3, Cedars-Sinai Medical Center, 8700 Beverly
Boulevard, Los Angeles, CA 90048. E-mail: dcohn@xchg.peds
.csmc.edu
 1998 by The American Society of Human Genetics. All rights reserved.
0002-9297/98/6301-0020$02.00
fusion. The term “multiple synostoses syndrome” was
first coined by Maroteaux et al. (1972). Numerous other
synonyms and eponyms have been assigned to this dis-
order, including WL syndrome, deafness of Herrmann,
and facio-audio-symphalangism (Furhmann et al. 1966;
Herrmann 1974; Hurvitz et al. 1985). In addition to the
ankylosis, affected individuals have characteristic facial
manifestations that include a broad hemicylindrical
nose, with lack of alar flare, and a thin upper vermilion.
Most affected individuals also develop early-onset oto-
sclerotic deafness that typically responds to stapedec-
tomy (Gaal et al. 1987).
In multiple synostoses syndrome, joint ankylosis be-
gins in early childhood and is progressive. The fifth prox-
imal interphalangeal joint is usually the first to be af-
fected, and the ankylosis proceeds in an ulnar-to-radial
and proximal-to-distal direction, typically involving
digits 3, 4, and 5. The carpal and tarsal bones, the radius,
and the humerus are also involved. Other findings in-
clude clinodactyly, brachydactyly, a shortened hallux,
syndactyly of toes 2 and 3, and mild short stature. Ra-
diographs document the natural history of the disease,
by demonstration of multiple areas of progressive joint-
space narrowing and resultant joint fusions.The inter-
phalangeal joint spaces begin to narrow at an early age,
and phalangeal bone fusions develop subsequently. Fre-
quently, the vertebral, humeroradial, and hip joints are
simultaneously involved.
Multiple synostoses syndrome shares clinical similar-
ities with proximal symphalangism (SYM1 [OMIM
185800]). Both disorders present with early onset and
progressive symphalangism, and some patients with
SYM1 manifest conductive hearing loss (Strasburger
1965). Polymeropoulos et al. (1995) localized the disease
gene for SYM1 to an ∼30-cM interval, flanked by the
loci D17S579 and D17S795, on chromosome 17q21-
22. Using a single large Hawaiian family with multiple
synostoses syndrome, we tested the hypothesis that the
multiple synostoses–syndrome disease gene is located in
the SYM1 gene region. Linkage analyses of these data
provided strong evidence that the disease gene for mul-
Krakow et al.: Mapping of MSS to 17q21-22 121
Figure 1 Pedigree of the Hawaiian family with multiple synostoses syndrome, showing the most likely haplotypes for the chromosome
17 markers. The haplotype linked to multiple synostoses syndrome is boxed.
tiple synostoses syndrome is within a 16-cM interval at
17q21-22 that is completely contained within the SYM1
interval, suggesting that the two disorders are allelic.
Material and Methods
Ascertainment
Each of 25 family members who agreed to participate
was examined by one of us (D.K., D.L.R., B.P., or K.R.).
Individuals were scored as affected if they had evidence
of limited flexion of the fifth proximal interphalangeal
joint and/or fusions of multiple other joints. When ap-
propriate, we obtained radiographic evidence of sym-
phalangism or other joint fusions, to confirm the diag-
nosis. Clinical status could be determined unequivocally
for all participating family members. The study was ap-
proved by the hospital’s institutional review board.
DNA Typing
DNA was extracted from blood by use of the Puregene
kit (Gentra). Polymorphic short tandem-repeat markers
from the SYM1 region on 17q21-22 were applied to this
family. Linkage refinement was conducted with markers
from the Whitehead Institute for Biomedical Research
(Hudson et al. 1995), the Cooperative Human Linkage
Center (Murray et al. 1994), and Ge´ne´thon (Dib et al.
1996). All primer sequences are available through either
the Genome Database or the Whitehead Institute. Prim-
ers were obtained from Research Genetics. Fragments
containing the microsatellites were amplified by PCR,
the products were separated on 6% denaturing poly-
acrylamide gels, and the alleles were scored by size.
Linkage Analysis
Linkage analysis was performed by the LINKAGE 5.1
computer program package (Lathrop and Lalouel 1984).
Two-point LOD scores between the disease gene and
each marker were calculated by means of the MLINK
program. The phenotype was coded as a fully penetrant
autosomal dominant trait with a disease-allele frequency
of .0001. Equal recombination frequencies for males and
females were assumed. Because allele frequencies in this
Hawaiian population are unknown, for each marker, the
allele frequencies were set at l/N, where N is the number
of observed alleles in the pedigree.
122 Am. J. Hum. Genet. 63:120–124, 1998
Figure 2 Composite of the proband. A, Characteristic facial findings in multiple synostoses syndrome, including long, narrow facies;
broad tubular nose, with lack of alar flare; and thin upper vermilion. B, Adult hand radiograph demonstrating symphalangism with significant
narrowing of the proximal interphalangeal joint of the fifth digit and progressive symphalangism of the middle interphalangeal and distal
interphalangeal joints of digits 3, 4, and 5. C, Recent lateral radiograph of the proband, showing cervical vertebral fusions of vertebrae 3, 4,
5, and 6.
Figure 3 Map of the multiple synostoses–syndrome gene region on chromosome 17q21-22. Genetic distances between the markers are
given in centimorgans. The bold line represents the multiple synostoses–syndrome interval based on recombination mapping.
Results
Clinical Presentation
A large Hawaiian family (International Skeletal Dys-
plasia Registry, reference R95-127) with multiple syn-
ostoses syndrome was initially identified by Gaal et al.
(1987). The family can trace the disorder back to the
first known affected individual, a Cherokee Indian who
arrived in the Hawaiian Islands in the 1870s. A partial
pedigree, showing the individuals studied in this inves-
tigation, is shown in figure 1. Affected individuals dem-
onstrated the cardinal features of the syndrome, includ-
ing a broad, tubular-shaped nose, otosclerotic deafness,
and multiple progressive joint fusions commencing in
the hand (fig. 2). All affected individuals examined have
some degree of hearing impairment, ranging from mild
to severe. Symphalangism was the most consistent find-
ing. The joint fusions were progressive, commencing in
the fifth proximal interphalangeal joint in early child-
hood (or at birth, in some individuals) and progressing
in an ulnar-to-radial and proximal-to-distal direction.
Most of the affected adults were unable to close their
hands into a fist. With increasing age, ankylosis of other
joints—including the cervical vertebrae, hips, and hu-
meroradial joints—develops. Many reports in the liter-
ature (Furhmann et al. 1966; Herrmann 1974; Hurvitz
et al. 1985) note the humeroradial and tarsal involve-
ment; however, little has been written regarding the ver-
tebral bodies. In the family reported here, the cervical
vertebral fusions commence in early childhood and ul-
timately produce significant limitation of neck flexion
and extension.
Linkage Analysis
Since multiple synostoses syndrome shares clinical
findings with SYM1, a disorder localized to chromosome
17q21-22 (Polymeropoulos et al. 1995), polymorphic
markers from the SYM1 region were applied in this fam-
ily. The SYM1 region on chromosome 17 was defined
by D17S579 on the centromeric limit and by D17S795
on the telomeric boundary (see fig. 3), an interval of ∼30
cM (Polymeropoulos et al. 1995). Initially, a suggestive
LOD score of 2.3 at recombination fraction (v) of .00
was obtained for the marker at locus D17S797, and,
subsequently, a LOD score of 3.98 ( ) was cal-v  .00
culated for the marker at locus D17S787. Two-point
LOD scores for additional markers from the region are
given in table 1.
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Table 1
Two-Point LOD Scores between Multiple Synostoses Syndrome and
Markers at Loci on Chromosome 17
LOCUS
LOD SCORE AT v 
.00 .01 .05 .10 .20 .30 .40
D17S579  12.3 2.42 .96 .08 .31 .19
D17S791  5.75 1.86 .45 .51 .65 .42
D17S797 2.31 2.27 2.10 1.88 1.41 .93 .43
D17S787 3.98 3.92 3.68 3.34 2.57 1.68 .73
D17S792  2.27 2.68 2.61 2.10 1.36 .53
D17S944  1.17 .72 1.31 1.52 1.22 .63
Haplotypes were constructed by parsimony and are
shown with the pedigree in figure 1. Four key recom-
binant events were identified, which allowed the interval
containing the disease gene to be narrowed. In individ-
uals II-11, III-12, and IV-l, a recombination between the
markers at loci D17S931 and D17S809 established the
centromeric limit of the disease-gene region at D17S931.
This recombination was confirmed by the haplotype of
IV-7, the daughter of III-12, who inherited the recom-
binant chromosome. The genetic locations for the mark-
ers at loci D17S931 and D17S797 are estimated to be
similar. For the haplotype analysis, D17S931 was used
because of the informativeness of the marker, compared
with D17S797, at that locus. A recombination event in
individual III-9, between the markers at loci D17S792
and D17S944, defined the telomeric boundary of the
disease-gene interval at D17S792. Recombination map-
ping thus defined a 16-cM interval, between D17S931
and D17S792, that must contain the multiple synosto-
ses–syndrome gene.
Discussion
We found linkage of multiple synostoses syndrome to
loci on chromosome 17q21-22. SYM1, a distinct but
phenotypically similar autosomal dominant disorder,
has also been localized to chromosome 17q21-22. The
SYM1 interval was defined between the loci D17S579
and D17S795, an ∼30-cM region. The 16-cM multiple
synostoses–syndrome interval defined here is wholly
contained within the SYM1 interval, providing evidence
that they may be allelic disorders. Remaining recombi-
nants, three on the centromeric side and one on the
telomeric end, should allow the interval to be further
narrowed as additional markers are defined.
Although a number of genes and ∼140 expressed se-
quence tags have been localized to the multiple synos-
toses–syndrome interval, on the basis of tissue distri-
bution, none of them appear to be good functional
candidates. Some of the mapped genes in the region in-
clude the nucleolar transcription factor, cyclin A, and
myeloperoxidase precursor genes, but these are general
housekeeping genes that are not likely candidates for a
disorder of cartilage. The HOXB gene cluster, a set of
regulatory genes that specify anterior-posterior axis de-
velopment, has also been localized to chromosome
17q21-22. Furthermore, mutations in a HOX gene from
a different cluster, HOXD12 (Muragaki et al. 1996),
cause limb malformations and have been identified in
patients with synpolydactyly. Therefore, we considered
the possibility that the HOXB cluster might harbor a
disease-gene candidate. However, the primary site of ex-
pression of the HOXB genes is in the developing nervous
system (Krumlauf 1994), and there is no evidence that
the genes in the cluster, HOXB1–9, are expressed in
cartilage. Furthermore, although the HOXB cluster is
poorly mapped, the most likely location is in the
D17S791–D17S797 interval (Human Transcript Map;
Schuler et al. 1996), a region excluded by recombination
mapping in our family. Thus, it is unlikely that mutations
in one of the HOXB genes produces multiple synostoses
syndrome.
Although geneticists have considered SYM1 and mul-
tiple synostoses syndrome to be genetically distinct dis-
orders, the present linkage data suggest that they may
be allelic. Clinically, two of the cardinal features seen in
multiple synostoses syndrome—joint ankylosis and deaf-
ness—are seen in SYM1. Most interestingly, the pattern
of expression of the symphalangism in both disorders
follows a reproducible topographic course. It com-
mences on the ulnar side and progresses radially, and it
affects the proximal interphalangeal joints first and then
advances to the distal joints. Thus, because the joint
ankylosis extends beyond the phalanges, wrists, and an-
kles, multiple synostoses syndrome represents the more
severe end of the clinical spectrum. In the family reported
here, there are also significant cervical vertebral, radio-
humeral, and hip-joint fusions. Whether this implies mu-
tations in two tightly linked genes or different mutations
in the same gene will be determined when the disease
gene is isolated. Both of these disorders are progressive.
From a mechanistic viewpoint, this implies an ongoing
accumulation of an abnormal protein or, conversely, the
absence of the function of a key gene involved in the
maintenance of joint integrity. Because genes with pri-
mary responsibility for maintenance of the joint space
have yet to be defined, isolation of the multiple synos-
toses–syndrome gene may provide new insights into one
of the molecular mechanisms responsible for this
process.
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